Medicare Enrolled
Dr. Craig Mansour, MD
Cardiovascular Disease · Ventura, CA
Practice pattern: Cardiac & Remote
— Practice combining cardiac and remote services
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Mansour from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Mansour?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Mansour
Dr. Craig Mansour is a cardiovascular disease specialist in Ventura, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Mansour performed 6,457 Medicare services across 3,533 unique beneficiaries.
Between the years covered by Open Payments, Dr. Mansour received a total of $7,511 from 32 pharmaceutical and/or device companies across 390 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Mansour is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 13% volume in CA
$7,511 industry payments
Medicare Practice Summary
Medicare Utilization ↗6,457
Medicare services
Top 13% in CA for cardiovascular disease
3,533
Unique beneficiaries
$107
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~340 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,190 | $104 | $409 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
612 | $43 | $166 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
517 | $53 | $198 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
459 | $12 | $47 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
459 | $177 | $661 |
| Chronic care management, additional 20 min/month This service covers an extra 20 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions each calendar month. |
332 | $41 | $151 |
| Remote monitoring of implantable heart rhythm device Evaluation of data transmitted remotely from an implantable cardiovascular monitor, such as a loop recorder or subcutaneous cardiac rhythm monitor, over a period up to 30 days. |
326 | $28 | $41 |
| Remote cardiac rhythm monitor evaluation, up to 30 days Review and analysis of data from a remote cardiac rhythm monitoring system over a period of up to 30 days. |
284 | $21 | $80 |
| Remote pacemaker monitoring, 90 days Remote assessment of a pacemaker system, including single, dual, multiple lead, or leadless devices, performed up to 90 days apart. |
216 | $24 | $93 |
| Remote pacemaker/defibrillator monitoring, 90 days Remote evaluation of a pacemaker or implantable defibrillator system within 90 days of the last check. |
214 | $20 | $80 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 212 | $417 | $1,200 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
175 | $146 | $570 |
| Continuous external EKG monitoring, 8-15 days This procedure involves recording heart rhythm continuously using an external EKG device over a period of 8 to 15 days. |
108 | $11 | $42 |
| External EKG monitoring, 8-15 days Continuous external electrocardiogram recording and review over a period of 8 to 15 days to monitor heart rhythm. |
108 | $21 | $80 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
104 | $125 | $530 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
101 | $67 | $244 |
| Technetium Tc-99m sestamibi diagnostic injection A diagnostic injection of technetium Tc-99m sestamibi used for imaging studies. |
98 | $44 | $365 |
| Echocardiogram, transthoracic An ultrasound test that uses sound waves to create images of the heart's blood flow, valves, and chambers. |
89 | $46 | $170 |
| Echocardiogram with color Doppler An ultrasound of the heart that uses color imaging to visualize blood flow, measure flow rate, and assess valve function. |
89 | $22 | $81 |
| Stress echocardiogram with ECG monitoring An ultrasound of the heart performed while monitoring heart rhythm during rest, exercise, or medication-induced stress, followed by a review and report of the findings. |
89 | $201 | $780 |
| Pacemaker programming, dual lead system Adjustment and configuration of a dual-lead pacemaker device to ensure proper operation and settings. |
68 | $53 | $195 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
65 | $70 | $290 |
| Nuclear stress test with CT scan A nuclear medicine imaging test that evaluates blood flow in the heart muscle at rest and during stress, performed alongside a concurrent CT scan. |
54 | $1,747 | $6,540 |
| PET scan of heart muscle blood flow A nuclear medicine imaging test that uses positron emission tomography (PET) to evaluate blood flow within the heart muscle. |
53 | $124 | $468 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle while at rest and during stress. |
51 | $1,368 | $5,145 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
50 | $406 | $1,507 |
| Continuous external EKG monitoring, 48 hours to 7 days This procedure involves recording the heart's electrical activity continuously using an external device for a period exceeding 48 hours but not more than 7 days. |
50 | $11 | $42 |
| Continuous EKG monitoring review, 48-7 days Review and interpretation of continuous external EKG recordings lasting more than 48 hours up to 7 days. |
50 | $19 | $72 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
48 | $141 | $539 |
| 2-day continuous ECG with review and report A two-day continuous electrocardiogram recording that includes a professional review and written report of the results. |
33 | $62 | $248 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
29 | $42 | $152 |
| Cardiac catheterization | 25 | $236 | $873 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while an electrocardiogram is monitored under physician supervision. |
22 | $18 | $65 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram, with physician review of the results. |
22 | $12 | $43 |
| Pacemaker programming, single lead Adjustment and testing of a single-lead pacemaker to ensure it functions correctly. |
21 | $27 | $152 |
| Transesophageal echocardiogram An ultrasound of the heart performed using a probe inserted into the esophagus to obtain detailed images of heart structures and function. |
20 | $89 | $326 |
| Follow-up heart ultrasound An ultrasound of the heart performed to monitor or reassess a previously identified condition or treatment progress. |
14 | $21 | $76 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
16.9% high complexity
17.4% medium
65.7% routine
Industry Payment Transparency
Open Payments through 2024 ↗$7,511
Total received (2018-2024)
Avg $1,073/year across 7 years
Top 32% in CA for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
32
Companies
390
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,511 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,734
2023
$1,302
2022
$1,378
2021
$1,051
2020
$912
2019
$625
2018
$510
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$283
PFIZER INC.
$279
Boehringer Ingelheim Pharmaceuticals, Inc.
$193
Amgen Inc.
$191
Kiniksa Pharmaceuticals International, plc
$159
Boston Scientific Corporation
$130
Merck Sharp & Dohme LLC
$110
Lexicon Pharmaceuticals, Inc.
$77
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$70
AstraZeneca Pharmaceuticals LP
$64
E.R. Squibb & Sons, L.L.C.
$55
Abbott Laboratories
$36
Impulse Dynamics (USA) Inc.
$26
CVRx, Inc.
$24
iRhythm Technologies, Inc.
$19
Esperion Therapeutics, Inc.
$18
Top 3 companies account for 43.5% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$1,261
Novartis Pharmaceuticals Corporation
$1,101
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$736
Boston Scientific Corporation
$593
Abbott Laboratories
$555
Boehringer Ingelheim Pharmaceuticals, Inc.
$493
PFIZER INC.
$485
E.R. Squibb & Sons, L.L.C.
$276
Medtronic, Inc.
$241
Janssen Pharmaceuticals, Inc
$216
Merck Sharp & Dohme LLC
$198
AstraZeneca Pharmaceuticals LP
$187
Kiniksa Pharmaceuticals International, plc
$159
Kowa Pharmaceuticals America, Inc.
$92
iRhythm Technologies, Inc.
$91
Merck Sharp & Dohme Corporation
$89
CVRx, Inc.
$85
Amarin Pharma Inc.
$81
Lexicon Pharmaceuticals, Inc.
$77
Esperion Therapeutics, Inc.
$75
Lundbeck LLC
$60
Baxter Healthcare
$56
Kiniksa Pharmaceuticals, Ltd.
$54
SANOFI-AVENTIS U.S. LLC
$44
Edwards Lifesciences Corporation
$40
Medtronic Vascular, Inc.
$34
Impulse Dynamics (USA) Inc.
$26
ITI, Inc.
$26
Alexion Pharmaceuticals, Inc.
$26
BOSTON SCIENTIFIC CORPORATION
$24
Allergan Inc.
$15
Regeneron Healthcare Solutions, Inc.
$12
Top 3 companies account for 41.3% of all-time payments
Associated products mentioned in payments ›
ACCOLADE · ANDEXXA · ATTAIN COMMAND + SUREVALVE · AVEIR · Arcalyst · Attain · BELSOMRA · BRILINTA · Barostim Neo System · CAMZYOS · CAPLYTA · CHANTIX · COREVALVE EVOLUT R · CareLink · Confirm Rx · Corlanor · ELIQUIS · ENTRESTO · Edwards SAPIEN 3 Transcatheter Heart Valve · Edwards SAPIEN 3 Ultra Transcatheter Heart Valve · FARXIGA · FIRMap Catheters · GALLANT · GENERAL TACHY · GENERAL - BRADY · GENERAL - TACHY · Hillrom - Cardiac Ambulatory Monitor · INGEVITY · Inpefa · JARDIANCE · LATITUDE · LEQVIO · LINQ II · LINZESS · LUX DX · LUX-Dx Insertable Cardiac Monitor · LifeVest · Livalo · MICRA · MITRACLIP · MULTAQ · Micra · Mitra Clip system · NEXLETOL · NORTHERA · Optimizer · PRADAXA · PRALUENT ALIROCUMAB INJECTION · REVEAL LINQ · Repatha · Reveal LINQ · TYRX · VERQUVO · VYNDAQEL · Vascepa · WAINUA · WATCHMAN · WATCHMAN Access System · XARELTO · ZIO Patch · ZIO XT Patch
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Cardiologists within 10 mi
39
Per 100K population
4.7
County median income
$107,327
Nearest hospital
VENTURA COUNTY MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Mansour is a cardiac & remote specialist, with above-average Medicare volume (top 13% in CA), with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Mansour experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Mansour performed 1,190 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Mansour receive payments from pharmaceutical companies?
Yes. Dr. Mansour received a total of $7,511 from 32 companies across 390 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Mansour's costs compare to other cardiologists in Ventura?
Dr. Mansour's average Medicare payment per service is $107. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Mansour) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in Ventura
Browse cardiologists in Ventura ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in CA
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in CA
Which CA cardiologists receive the most from drug and device companies.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) Payments to Doctors
See all physicians who received payments from ZOLL Services LLC (A/K/A ZOLL LifeCor Corp).
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology